Libin Yan, Lin Lin, Wadih Issa, Shahed Abdullah, Panayiotis Dimitrios Kontoyiannis, Mia Hofstad, Charles Jiang, Qian Qin, Suzanne Cole, Waddah Arafat, Jue Wang, Kevin Dale Courtney, Joseph Vento, Kris Gaston, Vitaly Margulis, Solomon L. Woldu, Yair Lotan, Neil Desai, Andrew Zhuang Wang, Tian Zhang. "Clinical outcomes for patients (pts) with synchronous versus metachronous metastatic urothelial cancer (mUC) treated with enfortumab vedotin and pembrolizumab (EV-P).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4587